EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
about
FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1An expression screen reveals modulators of class II histone deacetylase phosphorylationThe aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signallingSphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progressS1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species.Sphingosine kinase and sphingosine 1-phosphate in cardioprotection.Characterization and Expression of Sphingosine 1-Phosphate Receptors in Human and Rat Heart.Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?Sphingolipids in obesity, type 2 diabetes, and metabolic disease.Granule cargo release from bone marrow-derived cells sustains cardiac hypertrophy.Dietary fatty acids alter left ventricular myocardial gene expression in Wistar rats.Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites.S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease.Sphingosine-1-phosphate inhibits nuclear factor kappaB activation and germ cell apoptosis in the human testis independently of its receptors.The impact of bioactive lipids on cardiovascular development.Implication of sphingosin-1-phosphate in cardiovascular regulation.Increased sphingosine-1-phosphate improves muscle regeneration in acutely injured mdx mice.Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.Nuclear and mitochondrial signalling Akts in cardiomyocytesAkt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue.Sphingosine-1-phosphate receptor signalling in the heart.β1-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapySphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia.Sphingosine kinase activity is required for sphingosine-mediated phospholipase D activation in C2C12 myoblastsRegulated and constitutive activation of specific signalling pathways by the human S1P5 receptor.Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6.Sphingosine 1-phosphate to p38 signaling via S1P1 receptor and Gαi/o evokes augmentation of capsaicin-induced ionic currents in mouse sensory neurons.Sphingosine modulation of cAMP levels and beating rate in rat heart.Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction.Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.TGF-β/Smad3 pathway enhances the cardio-protection of S1R/SIPR1 in in vitro ischemia-reperfusion myocardial cell model.ADAP1 limits neonatal cardiomyocyte hypertrophy by reducing integrin cell surface expression
P2860
Q24298835-29FD6E2B-2301-4263-94C5-D7DEC824EFE0Q24304114-301054A0-26C3-4F0C-A236-34D35B620918Q24529925-C708D681-21FE-4769-ACA6-DA1FD25D6826Q27001065-46028E5D-C72A-4D51-A9D0-5655454C772BQ33573630-B008FC5B-C0A6-4515-AB25-84F6F0CA89A4Q33715344-140B9973-D534-494F-A536-06AF49834D9BQ33720344-2779E726-0317-4FB1-8C6A-380E97F635ADQ33753317-4535C50C-875E-40FD-8659-80D3B8E133CEQ33880588-888BFA21-A29F-4AD9-850B-2A75255B12FEQ34519433-551014F7-A06D-4D45-9989-CC7EF705AF60Q34696146-3B5AC6C9-1D0C-4D86-952D-E67B6CBCE2CAQ35048357-B349E4C7-5934-43A8-8D4D-CEB4C2C4B746Q35049449-EF753742-9857-475E-A6C7-50FBC7F7BBDBQ35083754-995AA3B2-E80E-4892-8DE9-51F4FC2C97F2Q35173287-5C682F2F-21AD-42D0-8F36-7945703BCDB4Q36898368-5CBB7C70-D59F-46F8-BD06-1D4C594FCCD8Q37114072-299C97D9-E696-4FB0-9260-D5BDD3E10D2DQ37162539-064C4F0A-1170-4223-8D85-AC47CABF5C82Q37176193-49E1476D-7816-4870-AE31-D1197344DC7BQ37319985-2291816D-98C9-4746-B175-DE3D929BB1FAQ37413862-3BBAE18E-7DD1-4A3C-BFF5-736D598433C7Q38266154-C5BD987F-96CA-4407-AB66-3B305EBD6C31Q38937414-C85CE537-E5C6-4A42-9ED4-025D66AA0AF0Q39681091-0D889E1A-BCF5-46A3-9FE1-49697AB9A8B4Q40562914-438B306F-77F0-4196-A13B-5FB0BED7F3F0Q40672751-046C2C00-F63C-4E7A-A475-981AA3C8B162Q41237635-F62C4FA4-B9FF-41E2-91EC-D3F13FC04C40Q41980318-C5A827E3-58F8-41EA-9ED5-BB215EC269F3Q42439515-F8F59F0A-1F1F-428F-9163-C641C137B3A3Q43287633-94FA3062-1077-416C-8227-AD22BE5F0CD8Q46024801-370C3E27-3481-4F8A-A973-7FA2ECF0340FQ46158490-6E676C6F-720F-43A0-AA94-229A0BFFBC57Q50910267-CF0CFAD8-517E-495D-9A9E-8AD0E82B8883Q55278796-6622E6EC-B676-459B-9A6C-B5B309EF21B6Q55342846-6BB34EEA-7049-4DC2-B1BD-F20C5A62B5D4Q58751874-413916D6-14FD-4B79-802E-C8170EC9A8A2
P2860
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
description
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im September 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/09/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/09/01)
@nl
наукова стаття, опублікована у вересні 2001
@uk
مقالة علمية (نشرت في سبتمبر 2001)
@ar
name
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
@ast
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
@en
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
@nl
type
label
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
@ast
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
@en
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
@nl
prefLabel
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
@ast
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
@en
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
@nl
P2093
P356
P1476
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
@en
P2093
G. P. Livi
H. M. Sarau
I. Berrebi-Bertrand
M. P. Laville
P304
P356
10.1006/JMCC.2001.1433
P577
2001-09-01T00:00:00Z